DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ: 067080)

Market Cap	200.22B
Revenue (ttm)	115.31B
Net Income (ttm)	10.76B
Shares Out	17.52M
EPS (ttm)	617.61
PE Ratio	18.51
Forward PE	n/a
Dividend	150.00 (1.31%)
Ex-Dividend Date	Dec 27, 2024

Volume	322,394
Open	12,250
Previous Close	12,250
Day's Range	11,450 - 12,360
52-Week Range	8,290 - 24,150
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 7, 2025

About DAE HWA Pharmaceutical

DAE HWA Pharmaceutical Co., Ltd., a pharmaceutical company, produces and supplies pharmaceutical products in South Korea. The company offers drugs for anticancer, antibiotics, antifungal and skin ailment, antivirus, anti-allergosis, hemorrhoids, antidepressant, antiepileptic, psychotropic agent, anti respiratory, anti-inflammatory, analgesic, skeletal muscle relaxants, osteoporosis, anti-arthritis, gastro-intestinal, obesity, antispasmodic, diabetics, hypertension, hyperlipemia, antithrombotic and anticoagulant, hepatic, erectile dysfunction, u...

• Industry: Pharmaceutical Preparations
• Founded: 1984
• Employees: 308
• Stock Exchange: KOSDAQ
• Ticker Symbol: 067080

Financial Performance

In 2019, DAE HWA Pharmaceutical's revenue was 114.61 billion, an increase of 4.06% compared to the previous year's 110.14 billion. Earnings were 10.54 billion, an increase of 58.55%.